StockWatch
·
Pharmaceuticals
Board Meeting27 Oct 2026, 12:41 pm

Acutaas Chemicals Ltd Board Approves Unaudited Financial Results

AI Summary

Acutaas Chemicals Ltd announced that its Board of Directors, in a meeting held on October 27, 2026, considered and approved the Unaudited Standalone & Consolidated Financial Results for the second quarter and half-year ended September 30, 2026. The Board also approved the Balance Sheet and Cash Flow Statement for the half-year ended September 30, 2026. These results were reviewed and recommended by the Audit Committee and accompanied by a Limited Review Report from the Statutory Auditors, M/s Maheshwari & Co. The meeting commenced at 11:30 AM and concluded at 2:35 PM.

Key Highlights

  • Board approved unaudited standalone and consolidated financial results.
  • Results are for the second quarter and half-year ended September 30, 2026.
  • Balance Sheet and Cash Flow Statement for the half-year were also approved.
  • Audit Committee reviewed and recommended the financial results.
  • Statutory Auditors issued a Limited Review Report.